GlassScriptPhysician profile
Ryan M Lebreton
NPI 1528042769
$12,628.00
in general payments reported to CMS, 2019-2025
9 companies · $222 in 2025
The $222 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $1,174 · 2021: $200 · 2022: $53.04 · 2023: $100 · 2024: $269 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $591.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maculogix, INC. | $11,566.75 | 2019-2020 | |
| Alcon Vision LLC | $538.00 | 2019-2025 | Precision7, Total30, Precision 1 |
| Lkc Technologies, INC. | $240.84 | 2023-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $128.74 | 2019-2021 | |
| Optos, INC. | $53.41 | 2020 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Coopervision INC. | $30.80 | 2023 | Myday Contact Lens |
| Biotissue Holdings INC. | $18.45 | 2020 | |
| Horizon Therapeutics Plc | $12.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Lebreton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.